2025-04-08 - Analysis Report
## Philip Morris International Inc. (PM) Stock Report

**0. Overview:** Philip Morris International Inc. (PM) is a leading international tobacco company.

**1. Performance Comparison & Alpha/Beta Analysis:**

PM's cumulative return (82.79%) significantly outperformed the S&P 500's (VOO) cumulative return (73.15%) by 9.6 percentage points.  The relative divergence of 87.2% indicates that this outperformance is in the top 87.2% of historical comparisons between PM and the S&P 500. However, the alpha and beta values show inconsistent outperformance against the market.  While some periods show positive alpha (outperformance), indicating PM's stock price moved independently of market movements and generating excess returns. However, others show negative alpha, suggesting underperformance compared to the market. Beta values are mostly above 1 suggesting higher than average market volatility. The market capitalization (Cap(B)) shows consistent growth throughout the observed period.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 26.0% | 5.0% | -4.0% | 0.0 | 111.2 |
| 2016-2018  | -33.0% | 21.7% | -52.0% | 0.0 | 74.2 |
| 2017-2019  | -8.0% | 21.7% | -38.0% | -0.1 | 100.1 |
| 2018-2020  | -7.0% | 21.7% | -0.5 | 103.8 |
| 2019-2021  | 43.0% | 12.3% | -0.6 | 125.4 |
| 2020-2022  | 33.0% | 64.4% | -0.4 | 140.8 |
| 2021-2023  | 14.0% | 64.4% | 1.0 | 138.2 |
| 2022-2024  | 9.0% | 64.4% | 0.8 | 185.7 |
| 2023-2025  | 44.0% | 62.3% | 0.7 | 235.4 |


**2. Recent Price Movement:**

* **Closing Price:** $151.23
* **5-Day Moving Average:** $155.64
* **20-Day Moving Average:** $153.50
* **60-Day Moving Average:** $143.52

The price is currently below all three moving averages, suggesting a potential bearish short-term trend.  The recent price increase of $0.4 (0.27%) from the previous close is relatively small and does not indicate a significant sudden upward or downward movement.


**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.48 (Medium-High Risk)
* **RSI:** 47.87 (Slightly below neutral; neither overbought nor oversold)
* **PPO:** -0.41 (Bearish signal)
* **20-Day Relative Divergence Change:** +8.5% (Short-term upward trend)
* **Expected Return:** -13.1% (Negative expected return over the long term relative to the S&P 500).

The indicators present a mixed signal. While the short-term trend is slightly positive, the long-term outlook, based on the expected return, is negative compared to the S&P 500.  The relatively high MRI suggests caution.


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue     |
|------------|-------|-------------|
| 2024-10-24 | $1.98 | $9.91 B     |
| 2024-07-25 | $1.54 | $9.47 B     |
| 2024-04-26 | $1.38 | $8.79 B     |
| 2023-10-26 | $1.32 | $9.14 B     |
| 2024-10-24 | $1.32 | $9.14 B     |

Note: There's a duplicate entry for 2024-10-24.  Assuming this is an error, we see a general upward trend in both EPS and Revenue, with some quarterly fluctuations.  Further investigation into the duplication is needed.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $9.71B | 64.73% |
| 2024-09-30 | $9.91B | 66.04% |
| 2024-06-30 | $9.47B | 64.67% |
| 2024-03-31 | $8.79B | 63.66% |
| 2023-12-31 | $9.05B | 61.73% |

**Capital and Profitability:**

| Quarter | Equity     | ROE       |
|---------|------------|-----------|
| 2024-12-31 | $-11.75B  | 4.93%     |
| 2024-09-30 | $-9.69B   | -31.79%   |
| 2024-06-30 | $-9.74B   | -24.69%   |
| 2024-03-31 | $-10.31B  | -20.84%   |
| 2023-12-31 | $-11.22B  | -19.56%   |

Revenue remains relatively stable with high profit margins.  However, the negative equity and significantly fluctuating Return on Equity (ROE) raise concerns about the company's financial health.  Further analysis is required to understand the reasons behind the negative equity and volatile ROE.


**6. Overall Conclusion:**

PM has shown strong cumulative returns exceeding the S&P 500, but the consistency of this outperformance is questionable based on the alpha and beta analysis.  Recent price action is slightly bearish, and technical indicators provide mixed signals.  While revenue and profit margins are healthy, negative equity and volatile ROE are significant red flags requiring further investigation.  The negative expected return relative to the S&P 500 suggests that long-term investment in PM may not outperform the market, despite its past performance.  A deeper dive into the company's financials and an assessment of the reasons behind the negative equity and fluctuating ROE are crucial before making any investment decisions.
